Nephritic syndrome: Difference between revisions

(Created page with "Nephritic syndrome is a clinical syndrome resulting from '''glomerular inflammation (glomerulonephritis)''', characterized by '''hematuria''' (with dysmorphic RBCs and RBC casts), '''hypertension''', '''oliguria''', '''edema''', and '''subnephrotic proteinuria'''.<ref name="StatPearls">Nephritic Syndrome. ''StatPearls''. NCBI. 2023.</ref> It is distinguished from Nephrotic syndrome primarily by the presence of '''hematuria and active urinary sediment'''. The EM physi...")
 
(Moved intro paragraph into Background section as bullets; removed excessive bold from bullet lead-ins throughout; added Glomerulonephritis causes and Hyperkalemia DDX template transclusions; bold retained only for critical items)
Line 1: Line 1:
Nephritic syndrome is a clinical syndrome resulting from '''glomerular inflammation (glomerulonephritis)''', characterized by '''hematuria''' (with dysmorphic RBCs and RBC casts), '''hypertension''', '''oliguria''', '''edema''', and '''subnephrotic proteinuria'''.<ref name="StatPearls">Nephritic Syndrome. ''StatPearls''. NCBI. 2023.</ref> It is distinguished from [[Nephrotic syndrome]] primarily by the presence of '''hematuria and active urinary sediment'''. The EM physician encounters nephritic syndrome as '''"cola-colored" urine in a child 1-3 weeks after a sore throat''' (post-streptococcal GN), '''acute renal failure with hypertension and pulmonary edema''', or '''hemoptysis with renal failure''' (pulmonary-renal syndrome). The key ED tasks are to '''recognize the syndrome via urinalysis''', '''manage life-threatening complications''' (hypertensive emergency, hyperkalemia, pulmonary edema, AKI), '''identify rapidly progressive glomerulonephritis (RPGN)''' as a true emergency requiring immediate nephrology involvement, and '''initiate targeted serologic workup'''.
==Background==
==Background==
*Nephritic syndrome is a clinical syndrome resulting from glomerular inflammation (glomerulonephritis), characterized by hematuria (with dysmorphic RBCs and RBC casts), hypertension, oliguria, edema, and subnephrotic proteinuria<ref name="StatPearls">Nephritic Syndrome. ''StatPearls''. NCBI. 2023.</ref>
*It is distinguished from [[Nephrotic syndrome]] primarily by the presence of hematuria and active urinary sediment
*The EM physician encounters nephritic syndrome as "cola-colored" urine in a child 1-3 weeks after a sore throat (post-streptococcal GN), acute renal failure with hypertension and pulmonary edema, or hemoptysis with renal failure (pulmonary-renal syndrome)
*The key ED tasks are to recognize the syndrome via urinalysis, manage life-threatening complications (hypertensive emergency, hyperkalemia, pulmonary edema, AKI), identify '''rapidly progressive glomerulonephritis (RPGN)''' as a true emergency requiring immediate nephrology involvement, and initiate targeted serologic workup
*Nephritic syndrome is a '''pattern of glomerular disease''', not a single diagnosis — many diseases present this way
*Nephritic syndrome is a '''pattern of glomerular disease''', not a single diagnosis — many diseases present this way
*'''Children:''' post-streptococcal glomerulonephritis (PSGN) is the most common cause
* Children: post-streptococcal glomerulonephritis (PSGN) is the most common cause
*'''Adults:''' IgA nephropathy, lupus nephritis, ANCA-associated vasculitis, and infection-associated GN are more common
* Adults: IgA nephropathy, lupus nephritis, ANCA-associated vasculitis, and infection-associated GN are more common
*The distinction between nephritic and nephrotic syndromes is fundamental to the ED evaluation of renal disease:
*The distinction between nephritic and nephrotic syndromes is fundamental to the ED evaluation of renal disease:


Line 34: Line 36:
==Clinical features==
==Clinical features==
===Classic acute nephritic syndrome===
===Classic acute nephritic syndrome===
*'''Hematuria:''' "cola-colored," "tea-colored," or "smoky" urine (gross hematuria); or microscopic hematuria
* Hematuria "cola-colored," "tea-colored," or "smoky" urine (gross hematuria); or microscopic hematuria
*'''Edema:''' periorbital (especially on waking), lower extremity; mild to moderate
* Edema periorbital (especially on waking), lower extremity; mild to moderate
*'''Hypertension:''' from sodium/water retention and intravascular volume expansion; may be '''severe'''
* Hypertension from sodium/water retention and intravascular volume expansion; may be '''severe'''
*'''Oliguria:''' reduced urine output (<400 mL/day in adults; <0.5 mL/kg/hr in children)
* Oliguria reduced urine output (<400 mL/day in adults; <0.5 mL/kg/hr in children)
*'''Proteinuria:''' present but usually subnephrotic
* Proteinuria present but usually subnephrotic
*'''Malaise, fatigue, anorexia, nausea'''
* Malaise, fatigue, anorexia, nausea
*'''Flank or abdominal pain''' (especially in children)
* Flank or abdominal pain (especially in children)
*Onset is often '''abrupt''' (days to 1-2 weeks)
*Onset is often '''abrupt''' (days to 1-2 weeks)


===Post-streptococcal glomerulonephritis (PSGN) — the prototype===
===Post-streptococcal glomerulonephritis (PSGN) — the prototype===
*'''Most common cause in children''' (ages 5-12 years); declining incidence in developed countries<ref name="GN">Glomerulonephritis. ''StatPearls''. NCBI. 2023.</ref>
* Most common cause in children (ages 5-12 years); declining incidence in developed countries<ref name="GN">Glomerulonephritis. ''StatPearls''. NCBI. 2023.</ref>
*'''Latent period:''' 1-2 weeks after pharyngitis; 3-6 weeks after skin infection (pyoderma/impetigo)
* Latent period 1-2 weeks after pharyngitis; 3-6 weeks after skin infection (pyoderma/impetigo)
*'''Not present during the infection''' — symptoms appear after a latent period (distinguishes from IgA nephropathy, which is synpharyngitic)
* Not present during the infection — symptoms appear after a latent period (distinguishes from IgA nephropathy, which is synpharyngitic)
*'''Gross hematuria''' in >50% of cases; "smoky" or "cola-colored" urine
* Gross hematuria in >50% of cases; "smoky" or "cola-colored" urine
*'''Edema and hypertension''' from salt/water retention
* Edema and hypertension from salt/water retention
*'''Low C3 complement''' (returns to normal within 6-8 weeks — failure to normalize suggests MPGN or C3 glomerulopathy)
* Low C3 complement (returns to normal within 6-8 weeks — failure to normalize suggests MPGN or C3 glomerulopathy)
*Usually '''self-limited''' in children (>95% recover completely); adults have worse prognosis
*Usually '''self-limited''' in children (>95% recover completely); adults have worse prognosis


===IgA nephropathy (Berger disease) — the most common GN worldwide===
===IgA nephropathy (Berger disease) — the most common GN worldwide===
*'''Synpharyngitic hematuria:''' gross hematuria occurring '''within 1-2 days''' of an upper respiratory infection (NOT after a latent period — key distinction from PSGN)<ref name="Wiki_Neph">Nephritic syndrome. ''Wikipedia''. 2025.</ref>
* Synpharyngitic hematuria: gross hematuria occurring '''within 1-2 days''' of an upper respiratory infection (NOT after a latent period — key distinction from PSGN)<ref name="Wiki_Neph">Nephritic syndrome. ''Wikipedia''. 2025.</ref>
*Recurrent episodes of gross hematuria
*Recurrent episodes of gross hematuria
*Between episodes: persistent microscopic hematuria ± proteinuria
*Between episodes: persistent microscopic hematuria ± proteinuria
*'''Normal complement levels''' (unlike PSGN)
* Normal complement levels (unlike PSGN)
*May overlap with [[Henoch-Schönlein purpura]] (IgA vasculitis) — systemic form with palpable purpura, arthritis, abdominal pain, and GN
*May overlap with [[Henoch-Schönlein purpura]] (IgA vasculitis) — systemic form with palpable purpura, arthritis, abdominal pain, and GN


===Rapidly progressive glomerulonephritis (RPGN) — the EM emergency===
===Rapidly progressive glomerulonephritis (RPGN) — the EM emergency===
*'''Defines >50% loss of renal function within 3 months'''
* Defines >50% loss of renal function within 3 months
*Nephritic sediment + '''rapidly rising creatinine''' over days to weeks
*Nephritic sediment + '''rapidly rising creatinine''' over days to weeks
*Pathologic hallmark: '''crescent formation''' in glomeruli on biopsy
*Pathologic hallmark: '''crescent formation''' in glomeruli on biopsy
*'''Three immunologic categories:'''
* Three immunologic categories:


{| class="wikitable"
{| class="wikitable"
Line 89: Line 91:


====Low C3 (hypocomplementemic)====
====Low C3 (hypocomplementemic)====
*'''Post-streptococcal GN''' (low C3; C4 normal or slightly low; normalizes by 6-8 weeks)
* Post-streptococcal GN (low C3; C4 normal or slightly low; normalizes by 6-8 weeks)
*'''Lupus nephritis''' (low C3 AND C4)
* Lupus nephritis (low C3 AND C4)
*'''MPGN / C3 glomerulopathy''' (persistently low C3)
* MPGN / C3 glomerulopathy (persistently low C3)
*'''Endocarditis-associated GN''' (low C3; blood cultures positive)
* Endocarditis-associated GN (low C3; blood cultures positive)
*'''Cryoglobulinemic GN''' (low C3 and C4; hepatitis C associated)
* Cryoglobulinemic GN (low C3 and C4; hepatitis C associated)


====Normal complement====
====Normal complement====
*'''IgA nephropathy'''
* IgA nephropathy
*'''ANCA-associated vasculitis (GPA, MPA)'''
* ANCA-associated vasculitis (GPA, MPA)
*'''Anti-GBM disease (Goodpasture)'''
* Anti-GBM disease (Goodpasture)
*'''Henoch-Schönlein purpura'''
* Henoch-Schönlein purpura
*'''Hereditary nephritis (Alport syndrome)'''
* Hereditary nephritis (Alport syndrome)


===Non-glomerular causes of hematuria to exclude===
===Non-glomerular causes of hematuria to exclude===
*'''Urinary tract infection''' (positive urine culture; normal RBC morphology)
* Urinary tract infection (positive urine culture; normal RBC morphology)
*'''Nephrolithiasis''' (flank pain; isomorphic RBCs; no casts)
* Nephrolithiasis (flank pain; isomorphic RBCs; no casts)
*'''Trauma'''
* Trauma
*'''Urologic malignancy''' (adults; painless hematuria)
* Urologic malignancy (adults; painless hematuria)
*'''Menstrual contamination'''
* Menstrual contamination
*'''Exercise-induced hematuria'''
* Exercise-induced hematuria


===Key to glomerular vs non-glomerular hematuria===
===Key to glomerular vs non-glomerular hematuria===
*'''Glomerular:''' dysmorphic RBCs (acanthocytes), '''RBC casts''' (virtually pathognomonic), proteinuria, brown/cola-colored urine, no clots
* Glomerular dysmorphic RBCs (acanthocytes), '''RBC casts''' (virtually pathognomonic), proteinuria, brown/cola-colored urine, no clots
*'''Non-glomerular:''' normal/isomorphic RBCs, no casts, pink/red urine, may have clots
* Non-glomerular normal/isomorphic RBCs, no casts, pink/red urine, may have clots
 
 
{{Glomerulonephritis causes}}
{{Hyperkalemia DDX}}


==Evaluation==
==Evaluation==
===ED workup===
===ED workup===
*'''Urinalysis with microscopy:''' the '''single most important test'''<ref name="AcuteGN">Acute Glomerulonephritis Workup. ''Medscape''. 2024.</ref>
* Urinalysis with microscopy the '''single most important test'''<ref name="AcuteGN">Acute Glomerulonephritis Workup. ''Medscape''. 2024.</ref>
**'''RBC casts:''' virtually pathognomonic for glomerulonephritis
** RBC casts: virtually pathognomonic for glomerulonephritis
**'''Dysmorphic RBCs''' (acanthocytes — best seen with phase-contrast microscopy; >30% dysmorphic is highly specific for glomerular origin)
** Dysmorphic RBCs (acanthocytes — best seen with phase-contrast microscopy; >30% dysmorphic is highly specific for glomerular origin)
**Proteinuria (usually 1-3+ on dipstick)
**Proteinuria (usually 1-3+ on dipstick)
**Sterile pyuria (WBCs without bacteria)
**Sterile pyuria (WBCs without bacteria)
*'''BMP/CMP:'''
* BMP/CMP:
**'''Creatinine''' (elevated = impaired GFR; trending creatinine is critical for identifying RPGN)
** Creatinine (elevated = impaired GFR; trending creatinine is critical for identifying RPGN)
**'''Potassium''' (hyperkalemia from impaired excretion — potentially life-threatening)
** Potassium (hyperkalemia from impaired excretion — potentially life-threatening)
**'''Bicarbonate''' (metabolic acidosis)
** Bicarbonate (metabolic acidosis)
**'''BUN''' (elevated; disproportionately elevated BUN:creatinine ratio in prerenal azotemia)
** BUN (elevated; disproportionately elevated BUN:creatinine ratio in prerenal azotemia)
*'''CBC:''' anemia (dilutional or from chronic disease); thrombocytopenia (TTP-HUS, SLE)
* CBC anemia (dilutional or from chronic disease); thrombocytopenia (TTP-HUS, SLE)
*'''Spot urine protein:creatinine ratio:''' quantifies proteinuria; helps distinguish nephritic (<3.5) from nephrotic (>3.5)
* Spot urine protein:creatinine ratio: quantifies proteinuria; helps distinguish nephritic (<3.5) from nephrotic (>3.5)
*'''Albumin:''' usually near-normal (mildly low at most); if markedly low, consider nephrotic overlap
* Albumin usually near-normal (mildly low at most); if markedly low, consider nephrotic overlap
*'''Blood pressure:''' frequently elevated; may be severely hypertensive
* Blood pressure frequently elevated; may be severely hypertensive


===Targeted serologic workup (initiate from ED based on clinical suspicion)===
===Targeted serologic workup (initiate from ED based on clinical suspicion)===
Line 158: Line 164:


===Imaging===
===Imaging===
*'''Renal ultrasound:''' assess kidney size (normal or enlarged in acute GN; small in chronic GN), exclude obstruction
* Renal ultrasound assess kidney size (normal or enlarged in acute GN; small in chronic GN), exclude obstruction
*'''Chest X-ray:''' if dyspnea (pulmonary edema, pulmonary hemorrhage/DAH), cough, hemoptysis
* Chest X-ray if dyspnea (pulmonary edema, pulmonary hemorrhage/DAH), cough, hemoptysis
*'''CT head:''' if hypertensive encephalopathy suspected (altered mental status, seizures, visual changes)
* CT head if hypertensive encephalopathy suspected (altered mental status, seizures, visual changes)
*'''Echocardiography:''' if endocarditis suspected
* Echocardiography if endocarditis suspected


===Renal biopsy===
===Renal biopsy===
*'''Not an ED procedure''' — arranged by nephrology
* Not an ED procedure — arranged by nephrology
*Indicated for most adults with nephritic syndrome (PSGN in children with typical presentation usually does not require biopsy)
*Indicated for most adults with nephritic syndrome (PSGN in children with typical presentation usually does not require biopsy)
*'''Urgent biopsy indications:''' suspected RPGN, rapidly deteriorating renal function, unclear diagnosis
* Urgent biopsy indications: suspected RPGN, rapidly deteriorating renal function, unclear diagnosis


==Management==
==Management==
Line 173: Line 179:
====Hypertensive emergency====
====Hypertensive emergency====
*May present with '''encephalopathy, seizures, visual changes, pulmonary edema'''
*May present with '''encephalopathy, seizures, visual changes, pulmonary edema'''
*'''Salt and water restriction'''
* Salt and water restriction
*'''Loop diuretics:''' furosemide 1-2 mg/kg IV (children) or 40-80 mg IV (adults) — first-line for volume-overload hypertension
* Loop diuretics furosemide 1-2 mg/kg IV (children) or 40-80 mg IV (adults) — first-line for volume-overload hypertension
*'''IV antihypertensives''' if diuretics insufficient: nicardipine infusion, labetalol, or hydralazine
* IV antihypertensives if diuretics insufficient: nicardipine infusion, labetalol, or hydralazine
*Avoid ACE inhibitors/ARBs in the '''acute''' setting with AKI and hyperkalemia (may worsen both)
*Avoid ACE inhibitors/ARBs in the '''acute''' setting with AKI and hyperkalemia (may worsen both)
*Target: gradual reduction; do not lower BP >25% in the first hour
*Target: gradual reduction; do not lower BP >25% in the first hour


====Hyperkalemia====
====Hyperkalemia====
*'''Impaired renal excretion''' → dangerous hyperkalemia
* Impaired renal excretion → dangerous hyperkalemia
*Manage per standard [[Hyperkalemia]] protocols: calcium gluconate (cardiac membrane stabilization), insulin + dextrose, albuterol, sodium bicarbonate, kayexalate/patiromer, dialysis if refractory
*Manage per standard [[Hyperkalemia]] protocols: calcium gluconate (cardiac membrane stabilization), insulin + dextrose, albuterol, sodium bicarbonate, kayexalate/patiromer, dialysis if refractory


====Pulmonary edema / volume overload====
====Pulmonary edema / volume overload====
*'''IV furosemide''' (high-dose may be needed with impaired GFR)
* IV furosemide (high-dose may be needed with impaired GFR)
*'''Oxygen, positive pressure ventilation''' (CPAP/BiPAP or intubation) if severe
* Oxygen, positive pressure ventilation (CPAP/BiPAP or intubation) if severe
*'''Fluid and sodium restriction'''
* Fluid and sodium restriction
*'''Dialysis''' if refractory pulmonary edema unresponsive to diuretics
* Dialysis if refractory pulmonary edema unresponsive to diuretics


====Pulmonary hemorrhage (pulmonary-renal syndrome)====
====Pulmonary hemorrhage (pulmonary-renal syndrome)====
*'''ICU admission'''
* ICU admission
*'''Urgent nephrology and pulmonology consultation'''
* Urgent nephrology and pulmonology consultation
*'''Plasma exchange (plasmapheresis):''' especially for anti-GBM disease (removes pathogenic antibodies)
* Plasma exchange (plasmapheresis): especially for anti-GBM disease (removes pathogenic antibodies)
*'''Pulse IV methylprednisolone''' (1 g daily for 3 days) ± cyclophosphamide — initiated by specialist
* Pulse IV methylprednisolone (1 g daily for 3 days) ± cyclophosphamide — initiated by specialist
*'''Intubation and mechanical ventilation''' if significant hemorrhage/respiratory failure
* Intubation and mechanical ventilation if significant hemorrhage/respiratory failure
*'''Type and crossmatch''' — transfuse for significant anemia from hemorrhage
* Type and crossmatch — transfuse for significant anemia from hemorrhage


===General ED management of acute nephritic syndrome===
===General ED management of acute nephritic syndrome===
*'''Fluid restriction:''' limit to insensible losses + urine output
* Fluid restriction limit to insensible losses + urine output
*'''Sodium restriction'''
* Sodium restriction
*'''Loop diuretics:''' for edema and hypertension
* Loop diuretics for edema and hypertension
*'''Monitor:''' urine output, blood pressure, electrolytes (especially potassium), creatinine q6-12 hours
* Monitor urine output, blood pressure, electrolytes (especially potassium), creatinine q6-12 hours
*'''Treat underlying infection:''' antibiotics for endocarditis; note that PSGN treatment targets the ''complication'' (not the strep infection itself — the GN is post-infectious; antibiotics do not alter the course of GN but may eradicate ongoing streptococcal infection)
* Treat underlying infection: antibiotics for endocarditis; note that PSGN treatment targets the ''complication'' (not the strep infection itself — the GN is post-infectious; antibiotics do not alter the course of GN but may eradicate ongoing streptococcal infection)
*'''Hold nephrotoxic medications:''' NSAIDs, aminoglycosides, contrast dye
* Hold nephrotoxic medications: NSAIDs, aminoglycosides, contrast dye


===Disease-specific treatment (nephrology-directed)===
===Disease-specific treatment (nephrology-directed)===
*'''PSGN:''' supportive care; usually self-limited; antibiotics only to eradicate residual streptococcal infection
* PSGN supportive care; usually self-limited; antibiotics only to eradicate residual streptococcal infection
*'''Lupus nephritis:''' corticosteroids ± mycophenolate mofetil or cyclophosphamide
* Lupus nephritis corticosteroids ± mycophenolate mofetil or cyclophosphamide
*'''ANCA-associated vasculitis:''' pulse steroids + cyclophosphamide or rituximab; plasma exchange for severe disease
* ANCA-associated vasculitis pulse steroids + cyclophosphamide or rituximab; plasma exchange for severe disease
*'''Anti-GBM disease:''' plasma exchange + steroids + cyclophosphamide — '''true emergency; outcomes are time-dependent'''
* Anti-GBM disease plasma exchange + steroids + cyclophosphamide — '''true emergency; outcomes are time-dependent'''
*'''IgA nephropathy:''' ACE inhibitor/ARB; immunosuppression for severe/progressive disease
* IgA nephropathy ACE inhibitor/ARB; immunosuppression for severe/progressive disease
*'''Endocarditis-associated GN:''' treat the endocarditis; immunosuppression is '''contraindicated''' (would worsen infection)
* Endocarditis-associated GN treat the endocarditis; immunosuppression is '''contraindicated''' (would worsen infection)


==Disposition==
==Disposition==
*'''Admit:'''
* Admit:
**Hypertensive emergency or severely elevated blood pressure
**Hypertensive emergency or severely elevated blood pressure
**Hyperkalemia
**Hyperkalemia
Line 222: Line 228:
**Significant AKI (creatinine >2x baseline, oliguria, need for dialysis)
**Significant AKI (creatinine >2x baseline, oliguria, need for dialysis)
**New-onset nephritic syndrome in adults (most require biopsy and specialist evaluation)
**New-onset nephritic syndrome in adults (most require biopsy and specialist evaluation)
*'''Consider discharge with close follow-up (48-72 hours):'''
* Consider discharge with close follow-up (48-72 hours):
**Child with classic PSGN presentation: mild edema + mild hypertension + stable renal function + no hyperkalemia + confirmed strep history
**Child with classic PSGN presentation: mild edema + mild hypertension + stable renal function + no hyperkalemia + confirmed strep history
**Ensure '''nephrology or pediatric nephrology follow-up''' within 48-72 hours
**Ensure '''nephrology or pediatric nephrology follow-up''' within 48-72 hours
**Return precautions: decreased urine output, worsening edema, headache, visual changes, seizures, difficulty breathing
**Return precautions: decreased urine output, worsening edema, headache, visual changes, seizures, difficulty breathing
*'''Always obtain nephrology consultation''' for: RPGN, pulmonary-renal syndrome, unclear diagnosis, adults with nephritic syndrome, renal failure requiring dialysis
* Always obtain nephrology consultation for: RPGN, pulmonary-renal syndrome, unclear diagnosis, adults with nephritic syndrome, renal failure requiring dialysis


==See Also==
==See Also==

Revision as of 12:51, 19 March 2026

Background

  • Nephritic syndrome is a clinical syndrome resulting from glomerular inflammation (glomerulonephritis), characterized by hematuria (with dysmorphic RBCs and RBC casts), hypertension, oliguria, edema, and subnephrotic proteinuria[1]
  • It is distinguished from Nephrotic syndrome primarily by the presence of hematuria and active urinary sediment
  • The EM physician encounters nephritic syndrome as "cola-colored" urine in a child 1-3 weeks after a sore throat (post-streptococcal GN), acute renal failure with hypertension and pulmonary edema, or hemoptysis with renal failure (pulmonary-renal syndrome)
  • The key ED tasks are to recognize the syndrome via urinalysis, manage life-threatening complications (hypertensive emergency, hyperkalemia, pulmonary edema, AKI), identify rapidly progressive glomerulonephritis (RPGN) as a true emergency requiring immediate nephrology involvement, and initiate targeted serologic workup
  • Nephritic syndrome is a pattern of glomerular disease, not a single diagnosis — many diseases present this way
  • Children: post-streptococcal glomerulonephritis (PSGN) is the most common cause
  • Adults: IgA nephropathy, lupus nephritis, ANCA-associated vasculitis, and infection-associated GN are more common
  • The distinction between nephritic and nephrotic syndromes is fundamental to the ED evaluation of renal disease:
Feature Nephritic syndrome Nephrotic syndrome
Primary mechanism Glomerular inflammation Podocyte injury (permeability defect)
Hematuria Prominent (dysmorphic RBCs, RBC casts) Absent or minimal
Proteinuria Subnephrotic (<3.5 g/day) Nephrotic-range (>3.5 g/day)
Edema Mild-moderate (volume overload) Severe (hypoalbuminemia)
Hypertension Prominent (salt/water retention) Variable
Serum albumin Normal or mildly low Markedly low (<3.0 g/dL)
Hyperlipidemia Absent Present
Urine sediment Active: RBC casts, dysmorphic RBCs, WBCs Bland: oval fat bodies, fatty casts; no RBC casts
Renal function Often impaired (elevated creatinine) Usually preserved early
  • Some diseases (MPGN, lupus nephritis, FSGS) can present with overlap features of both syndromes

Clinical features

Classic acute nephritic syndrome

  • Hematuria "cola-colored," "tea-colored," or "smoky" urine (gross hematuria); or microscopic hematuria
  • Edema periorbital (especially on waking), lower extremity; mild to moderate
  • Hypertension from sodium/water retention and intravascular volume expansion; may be severe
  • Oliguria reduced urine output (<400 mL/day in adults; <0.5 mL/kg/hr in children)
  • Proteinuria present but usually subnephrotic
  • Malaise, fatigue, anorexia, nausea
  • Flank or abdominal pain (especially in children)
  • Onset is often abrupt (days to 1-2 weeks)

Post-streptococcal glomerulonephritis (PSGN) — the prototype

  • Most common cause in children (ages 5-12 years); declining incidence in developed countries[2]
  • Latent period 1-2 weeks after pharyngitis; 3-6 weeks after skin infection (pyoderma/impetigo)
  • Not present during the infection — symptoms appear after a latent period (distinguishes from IgA nephropathy, which is synpharyngitic)
  • Gross hematuria in >50% of cases; "smoky" or "cola-colored" urine
  • Edema and hypertension from salt/water retention
  • Low C3 complement (returns to normal within 6-8 weeks — failure to normalize suggests MPGN or C3 glomerulopathy)
  • Usually self-limited in children (>95% recover completely); adults have worse prognosis

IgA nephropathy (Berger disease) — the most common GN worldwide

  • Synpharyngitic hematuria: gross hematuria occurring within 1-2 days of an upper respiratory infection (NOT after a latent period — key distinction from PSGN)[3]
  • Recurrent episodes of gross hematuria
  • Between episodes: persistent microscopic hematuria ± proteinuria
  • Normal complement levels (unlike PSGN)
  • May overlap with Henoch-Schönlein purpura (IgA vasculitis) — systemic form with palpable purpura, arthritis, abdominal pain, and GN

Rapidly progressive glomerulonephritis (RPGN) — the EM emergency

  • Defines >50% loss of renal function within 3 months
  • Nephritic sediment + rapidly rising creatinine over days to weeks
  • Pathologic hallmark: crescent formation in glomeruli on biopsy
  • Three immunologic categories:
Type Mechanism Classic disease Key lab findings
Type I (anti-GBM) Anti-glomerular basement membrane antibodies Goodpasture syndrome (anti-GBM + pulmonary hemorrhage) Anti-GBM antibodies positive; complement normal
Type II (immune complex) Immune complex deposition Lupus nephritis, PSGN (severe), IgA nephropathy, MPGN, endocarditis-related ANA, anti-dsDNA (lupus); low complement (C3, C4); cryoglobulins
Type III (pauci-immune) ANCA-associated vasculitis (minimal immune deposits) Granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) ANCA positive (c-ANCA/PR3 for GPA; p-ANCA/MPO for MPA); complement normal
  • RPGN is a true nephrology emergency — delay in treatment leads to irreversible ESKD
  • Requires immediate nephrology consultation, renal biopsy, and aggressive immunosuppression ± plasma exchange

Pulmonary-renal syndrome

  • Hemoptysis + nephritic syndrome = pulmonary-renal syndrome until proven otherwise
  • Causes: Goodpasture syndrome (anti-GBM), GPA, MPA, lupus, cryoglobulinemia
  • May present with diffuse alveolar hemorrhage (DAH): hemoptysis, dyspnea, bilateral infiltrates on CXR, dropping hemoglobin
  • Life-threatening — requires ICU admission, urgent nephrology and pulmonology consultation

Differential diagnosis

By complement level (high-yield ED approach)

Low C3 (hypocomplementemic)

  • Post-streptococcal GN (low C3; C4 normal or slightly low; normalizes by 6-8 weeks)
  • Lupus nephritis (low C3 AND C4)
  • MPGN / C3 glomerulopathy (persistently low C3)
  • Endocarditis-associated GN (low C3; blood cultures positive)
  • Cryoglobulinemic GN (low C3 and C4; hepatitis C associated)

Normal complement

  • IgA nephropathy
  • ANCA-associated vasculitis (GPA, MPA)
  • Anti-GBM disease (Goodpasture)
  • Henoch-Schönlein purpura
  • Hereditary nephritis (Alport syndrome)

Non-glomerular causes of hematuria to exclude

  • Urinary tract infection (positive urine culture; normal RBC morphology)
  • Nephrolithiasis (flank pain; isomorphic RBCs; no casts)
  • Trauma
  • Urologic malignancy (adults; painless hematuria)
  • Menstrual contamination
  • Exercise-induced hematuria

Key to glomerular vs non-glomerular hematuria

  • Glomerular dysmorphic RBCs (acanthocytes), RBC casts (virtually pathognomonic), proteinuria, brown/cola-colored urine, no clots
  • Non-glomerular normal/isomorphic RBCs, no casts, pink/red urine, may have clots


Causes of Glomerulonephritis

Hyperkalemia

  • Pseudohyperkalemia: hemolyzed specimen, prolonged tourniquet use prior to blood draw, thrombocytosis or leukocytosis
  • Redistribution (shift from intracellular to extracellular space)
  • Increased total body potassium
    • Inadequate excretion: Acute/chronic renal failure, Addison's disease, type 4 RTA
    • Drug-induced: potassium-sparing diuretic (spironolactone), angiotensin converting enzyme inhibitors (ACE-I), nonsteroidal anti-inflammatory drugs (NSAIDs)
    • Excessive intake: diet, blood transfusion
  • Other causes: succinylcholine, digitalis, beta-blockers

Evaluation

ED workup

  • Urinalysis with microscopy the single most important test[4]
    • RBC casts: virtually pathognomonic for glomerulonephritis
    • Dysmorphic RBCs (acanthocytes — best seen with phase-contrast microscopy; >30% dysmorphic is highly specific for glomerular origin)
    • Proteinuria (usually 1-3+ on dipstick)
    • Sterile pyuria (WBCs without bacteria)
  • BMP/CMP:
    • Creatinine (elevated = impaired GFR; trending creatinine is critical for identifying RPGN)
    • Potassium (hyperkalemia from impaired excretion — potentially life-threatening)
    • Bicarbonate (metabolic acidosis)
    • BUN (elevated; disproportionately elevated BUN:creatinine ratio in prerenal azotemia)
  • CBC anemia (dilutional or from chronic disease); thrombocytopenia (TTP-HUS, SLE)
  • Spot urine protein:creatinine ratio: quantifies proteinuria; helps distinguish nephritic (<3.5) from nephrotic (>3.5)
  • Albumin usually near-normal (mildly low at most); if markedly low, consider nephrotic overlap
  • Blood pressure frequently elevated; may be severely hypertensive

Targeted serologic workup (initiate from ED based on clinical suspicion)

Test What it identifies
C3, C4 complement Low C3: PSGN, lupus, MPGN, endocarditis GN; Low C3+C4: lupus, cryoglobulinemia
ASO titer, anti-DNase B Post-streptococcal GN (ASO elevated after pharyngitis; anti-DNase B after skin infection)
ANA, anti-dsDNA Lupus nephritis
ANCA (c-ANCA/PR3, p-ANCA/MPO) ANCA-associated vasculitis (GPA, MPA)
Anti-GBM antibodies Goodpasture syndrome / anti-GBM disease
Blood cultures Endocarditis-associated GN
Hepatitis B, C serologies Hepatitis-associated GN, cryoglobulinemia, MPGN
Cryoglobulins Cryoglobulinemic GN (often hepatitis C-associated)
HIV HIV-associated nephropathy
Serum IgA Elevated in ~50% of IgA nephropathy (nonspecific)

Imaging

  • Renal ultrasound assess kidney size (normal or enlarged in acute GN; small in chronic GN), exclude obstruction
  • Chest X-ray if dyspnea (pulmonary edema, pulmonary hemorrhage/DAH), cough, hemoptysis
  • CT head if hypertensive encephalopathy suspected (altered mental status, seizures, visual changes)
  • Echocardiography if endocarditis suspected

Renal biopsy

  • Not an ED procedure — arranged by nephrology
  • Indicated for most adults with nephritic syndrome (PSGN in children with typical presentation usually does not require biopsy)
  • Urgent biopsy indications: suspected RPGN, rapidly deteriorating renal function, unclear diagnosis

Management

Life-threatening emergencies (manage first)

Hypertensive emergency

  • May present with encephalopathy, seizures, visual changes, pulmonary edema
  • Salt and water restriction
  • Loop diuretics furosemide 1-2 mg/kg IV (children) or 40-80 mg IV (adults) — first-line for volume-overload hypertension
  • IV antihypertensives if diuretics insufficient: nicardipine infusion, labetalol, or hydralazine
  • Avoid ACE inhibitors/ARBs in the acute setting with AKI and hyperkalemia (may worsen both)
  • Target: gradual reduction; do not lower BP >25% in the first hour

Hyperkalemia

  • Impaired renal excretion → dangerous hyperkalemia
  • Manage per standard Hyperkalemia protocols: calcium gluconate (cardiac membrane stabilization), insulin + dextrose, albuterol, sodium bicarbonate, kayexalate/patiromer, dialysis if refractory

Pulmonary edema / volume overload

  • IV furosemide (high-dose may be needed with impaired GFR)
  • Oxygen, positive pressure ventilation (CPAP/BiPAP or intubation) if severe
  • Fluid and sodium restriction
  • Dialysis if refractory pulmonary edema unresponsive to diuretics

Pulmonary hemorrhage (pulmonary-renal syndrome)

  • ICU admission
  • Urgent nephrology and pulmonology consultation
  • Plasma exchange (plasmapheresis): especially for anti-GBM disease (removes pathogenic antibodies)
  • Pulse IV methylprednisolone (1 g daily for 3 days) ± cyclophosphamide — initiated by specialist
  • Intubation and mechanical ventilation if significant hemorrhage/respiratory failure
  • Type and crossmatch — transfuse for significant anemia from hemorrhage

General ED management of acute nephritic syndrome

  • Fluid restriction limit to insensible losses + urine output
  • Sodium restriction
  • Loop diuretics for edema and hypertension
  • Monitor urine output, blood pressure, electrolytes (especially potassium), creatinine q6-12 hours
  • Treat underlying infection: antibiotics for endocarditis; note that PSGN treatment targets the complication (not the strep infection itself — the GN is post-infectious; antibiotics do not alter the course of GN but may eradicate ongoing streptococcal infection)
  • Hold nephrotoxic medications: NSAIDs, aminoglycosides, contrast dye

Disease-specific treatment (nephrology-directed)

  • PSGN supportive care; usually self-limited; antibiotics only to eradicate residual streptococcal infection
  • Lupus nephritis corticosteroids ± mycophenolate mofetil or cyclophosphamide
  • ANCA-associated vasculitis pulse steroids + cyclophosphamide or rituximab; plasma exchange for severe disease
  • Anti-GBM disease plasma exchange + steroids + cyclophosphamide — true emergency; outcomes are time-dependent
  • IgA nephropathy ACE inhibitor/ARB; immunosuppression for severe/progressive disease
  • Endocarditis-associated GN treat the endocarditis; immunosuppression is contraindicated (would worsen infection)

Disposition

  • Admit:
    • Hypertensive emergency or severely elevated blood pressure
    • Hyperkalemia
    • Pulmonary edema or respiratory distress
    • Rapidly rising creatinine (suspect RPGN) — urgent nephrology consult
    • Pulmonary hemorrhage / pulmonary-renal syndrome — ICU
    • Significant AKI (creatinine >2x baseline, oliguria, need for dialysis)
    • New-onset nephritic syndrome in adults (most require biopsy and specialist evaluation)
  • Consider discharge with close follow-up (48-72 hours):
    • Child with classic PSGN presentation: mild edema + mild hypertension + stable renal function + no hyperkalemia + confirmed strep history
    • Ensure nephrology or pediatric nephrology follow-up within 48-72 hours
    • Return precautions: decreased urine output, worsening edema, headache, visual changes, seizures, difficulty breathing
  • Always obtain nephrology consultation for: RPGN, pulmonary-renal syndrome, unclear diagnosis, adults with nephritic syndrome, renal failure requiring dialysis

See Also

External Links

References

  1. Nephritic Syndrome. StatPearls. NCBI. 2023.
  2. Glomerulonephritis. StatPearls. NCBI. 2023.
  3. Nephritic syndrome. Wikipedia. 2025.
  4. Acute Glomerulonephritis Workup. Medscape. 2024.